Advertisement
Original Articles| Volume 46, ISSUE 12, P1682-1689, December 15, 1999

Download started.

Ok

Correlations of glutathione peroxidase activity with memory impairment in adults with down syndrome

      Abstract

      Background: Down syndrome (DS) is a genetic disorder (trisomy 21 in 96% of cases), associated with an excess of a key enzyme involved with free radical metabolism (FRM), superoxide dismutase-1 (SOD-1), that is encoded by a gene on chromosome 21. Consequently, SOD-1 activity is elevated in DS, which also occurs in conditions of oxidative stress, and is associated with a compensatory increase in glutathione peroxidase activity (GSHPx).
      Methods: This study examined the relationship of memory function with erythrocyte SOD-1, GSHPx and catalase (CAT) activity in 22–51 year old adults with DS.
      Results: Mean erythrocyte SOD-1 (p < .02) and GSHPx (p < .01), but not CAT (p = .76), activities were significantly greater in the DS group than the controls. In the DS group, erythrocyte GSHPx, but not SOD-1 or CAT activities, was significantly correlated with memory function (r = .625, p < .025, df = 13 for savings score, r = .631, p < .01, df = 14 for intrusion errors) but not with intelligence quotients.
      Conclusions: These observations suggest a possible relationship between altered FRM with memory deficits among adults with DS within the age-range in that an age-related increase in the prevalence for Alzheimer’s neuropathology is known to be robust before reaching a plateau of 100%.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ammeren K.
        • Epstein C.
        Lipid peroxidation and superoxide dismutase-1 and glutathione peroxidase activities in trisomy 21 fetal mice and human trisomy 21 fibroblasts.
        Pediatr Res. 1987; 21: 88-92
        • Beutler E.
        Red Cell Metabolism. 3rd ed. Grune & Stratton, Orlando, FL1984
        • Brooksbank B.
        • Balasz R.
        Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down’s syndrome fetal brain.
        Dev Brain Res. 1984; 16: 37-44
        • Brugge K.
        • Katzman R.
        • Hill R.
        • Hansen L.
        • Saitoh T.
        Serological alpha-1 antichymotrypsin in Down’s syndrome and Alzheimer’s disease.
        Ann Neurol. 1992; 32: 193-197
        • Brugge K.
        • Grove G.
        • Clopton P.
        • Grove M.
        • Piacquadio D.
        Evidence for accelerated skin wrinkling among developmentally delayed individuals with Down’s syndrome.
        Mech Aging Dev. 1993; 70: 213-225
        • Brugge K.
        • Nichols S.
        • Salmon D.
        • Hill L.
        • Delis D.
        • et al.
        Cognitive impairment in adults with Down’s syndrome.
        Neurology. 1994; 44: 232-238
        • Butters N.
        • Salmon D.
        • Cullum C.
        • Cairns P.
        • Troster A.
        • et al.
        Differentiation of amnesiac and demented patients with the Wechsler Memory Scale-Revised.
        Clin Neuropsychol. 1999; 2: 133-148
        • Ceballos-Picot I.
        • Delabar J.
        • Nicole A.
        • Lynch R.
        • Halliwell R.
        • et al.
        Expression of transfected human Cu-Zn superoxide dismutase gene in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity.
        Biochem Biophys Acta. 1988; 949: 58-64
        • Ceballos-Picot I.
        • Nicole A.
        • Briand P.
        • Grimber G.
        • Delacourte A.
        • et al.
        Expression of human Cu-Zn superoxide dismutase gene in transgenic mice.
        Free Radic Res Commun. 1991; 12: 581-589
        • Ceballos-Picot I.
        • Nicole A.
        • Briand P.
        • Grimber G.
        • Delacourte A.
        • et al.
        Neuronal-specific expression of human Cu-Zn superoxide dismutase gene in transgenic mice.
        Brain Res. 1991; 552: 198-214
        • Corey-Bloom J.
        • Weiderholt W.
        • Elestein J.
        • Salmon D.
        • Cahn D.
        • et al.
        Cognitive and functional status of the oldest old.
        J Am Geri Soc. 1996; 44: 671-674
        • Dalton A.
        • Seltzer G.
        • Adlin M.
        • Wisniewski H.
        Association between Alzheimer’s Disease and Down’s Syndrome. Oxford University Press, London1992
        • Delis D.
        • Massman P.
        • Butters N.
        • Salmon D.
        • Cermak L.
        • et al.
        Profiles of demented and amnesiac patients on the California Learning Test.
        Psychol Assess: J Consult Clin Psychol. 1991; 3: 19-26
        • Devenny D.
        • Silverman W.
        • Hill A.
        • Jenkins E.
        • Sersesn A.
        • et al.
        Normal aging in adults with Down’s syndrome.
        J Intel Dis Res. 1996; 40: 208-221
        • Ferrante A.
        • Thong Y.
        A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human bleed using a modification of the hypaque-ficoll technique.
        J Immunol Meth. 1978; 24: 389-393
        • Frants R.
        • Eriksson A.
        • Jongbloet P.
        • Hammers A.
        Superoxide dismutase in Down syndrome.
        Lancet. 1975; ii: 42-43
        • Groner Y.
        • Elroy-Stein O.
        • Avraham K.
        • Yarom R.
        • Schickler M.
        • et al.
        Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice over expressing the human Cu/Zn-superoxide dismutase gene.
        J Physiol. 1990; 84: 53-77
        • Halliwell B.
        Oxidants and the central nervous system.
        Acta Neurol Scand. 1989; 126: 23-33
        • Haxby J.
        • Schapiro M.
        Longitudinal study of neuropsychological function in older adults with Down syndrome.
        in: Nadel L. Epstein C. Down Syndrome and Alzheimer Disease. Wiley Liss, New York1992: 35-50
        • Heller J.
        Human chromosome aberrations as related to physical and mental dysfunction.
        J Hered. 1969; 60: 239
        • Higgins L.
        • Holtzman D.
        • Rabin B.
        • Mobley W.
        • Cordell B.
        Transgenic mouse brain histopathology resembles early Alzheimer’s disease.
        Ann Neurol. 1994; 35: 598-607
        • Jeziorowska A.
        • Jakubowski L.
        • Lach J.
        • Kaluzewski B.
        Regular trisomy 21 not accompanied by increased Cu-Zn superoxide dismutase (SOD1) activity.
        Clin Genet. 1988; 33: 11-19
        • Kaplan E.
        • Goodglass H.
        • Weintraub S.
        Boston Naming Test. Lea & Febiger, Philadelphia1983
        • Katzman R.
        • Saitoh T.
        Advances in Alzheimer’s disease.
        FASEB J. 1991; 5: 278-286
        • Kedziora J.
        • Bartosz
        Down’s syndrome.
        Free Radic Biol Med. 1988; 4: 317-330
        • Lott I.
        Down’s syndrome, aging, and Alzheimer’s disease.
        Ann NY Acad Sci. 1982; 396: 15-27
        • Mann D.
        • Royston M.
        • Ravindra C.
        Some morphometric observations on the brains of patients with Down syndrome.
        J Neurol Sci. 1990; 99: 153-164
        • Markesbery
        Oxidative stress hypothesis in Alzheimer’s disease.
        Free Radic Biol Med. 1997; 23: 134-147
        • Misra H.
        • Fridovich I.
        Superoxide dismutase and the oxygen enhancement of radiation lethality.
        Arch Biochem Biophys. 1976; 176: 577-581
        • Percy M.
        • Dalton A.
        • Markovic V.
        • Crapper McLachlan D.
        • Hummel J.
        • et al.
        Red cell superoxide dismutase, glutathione peroxidase and catalase in Down’s syndrome patients with and without manifestations of Alzheimer’s disease.
        Am J Med Genet. 1990; 35: 459-467
        • Rosen D.
        • Sidique T.
        • Patterson D.
        • Figlewica D.
        • Sapp P.
        • et al.
        Mutations in Cu/Zn superoxide dismutase gene are associated with familial Amyotrophic lateral sclerosis.
        Nature. 1993; 362: 59-62
        • Silverman W.
        • Popuvitch E.
        • Schupf N.
        • et al.
        Alzheimer neuropathology in mentally retarded adults.
        Acta Neuropathol. 1993; 85: 260-266
        • Sinet P.
        • Lejeune J.
        • Jerome H.
        Trisomy 21 (Down’s syndrome) glutathione peroxidase, hexose monophosphate shunt and I.Q.
        Life Sci. 1979; 24: 29-34
        • Takashima S.
        Down syndrome.
        Curr Opin Neurol. 1997; 10: 148-152
        • Thase M.
        • Tigner R.
        • Smeltzer P.
        • Liss L.
        Age-related neuropsychological deficits in Down’s syndrome.
        Biol Psychiatry. 1984; 19: 571-585
        • Tröster A.
        • Butters N.
        • Salmon D.
        • et al.
        The diagnostic utility of savings score.
        J Clin Exp Neuropsych. 1993; 15: 773-788
      1. Wechsler D (1981): Wechsler Adult Intelligence Scale-Revised: Manual. New York: Psychological Corporation.

      2. Wechsler D (1987): Wechsler Memory Scale-Revised. New York: Psychological Corporation.

        • Welsh K.
        • Butters N.
        • Hughes J.
        • Mohs R.
        • Heyman A.
        Detection and staging of dementia in Alzheimer’s disease.
        Arch Neurol. 1992; 49: 448-452
        • Wisniewski H.
        • Rabe A.
        Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down’s syndrome.
        Ann NY Acad Sci. 1986; 477: 247-259